Oncology Institute
STLN · NASDAQ
$6.63+$0.17 (+2.63%)TodayMarket closed ·
Prev close $6.46
Who owns STLN
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 38.9% of STLN’s shares.
- Chernett (Jorey)10.6%
- BlackRock Institutional Trust Company, N.A.4.2%
- OncologyCare Partners LLC4.1%
- M33 Growth LLC3.6%
- Next 6 largest institutions16.3%
- All other shareholders61.1%
| Holder | Shares | % of shares |
|---|---|---|
| Chernett (Jorey) | 10.64M | 10.64% |
| BlackRock Institutional Trust Company, N.A. | 4.20M | 4.21% |
| OncologyCare Partners LLC | 4.11M | 4.11% |
| M33 Growth LLC | 3.64M | 3.64% |
| Parian Global Management LP | 3.55M | 3.55% |
| Deerfield Management Company, L.P. | 3.36M | 3.36% |
| Vanguard Capital Management, LLC | 3.27M | 3.27% |
| Josh Arnold Investment Consultant, LLC | 2.46M | 2.46% |
| Geode Capital Management, L.L.C. | 1.90M | 1.90% |
| Wexford Capital LP | 1.71M | 1.71% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.40M | 2.40% |
| iShares Russell 2000 ETF | 1.99M | 1.99% |
| Nuveen Quant Small-Cap Equity Fund | 1.03M | 1.03% |
| Fidelity Small Cap Index Fund | 829.83K | 0.83% |
| Vanguard Extended Market Index Fund | 796.06K | 0.80% |
Short interest
Settled Sep 30, 2026
- Shares short
- 6.79M
- Days to cover
- 4.31
- % of shares outstanding
- 6.79%
- Average daily volume
- 1.58M
- Change since last report
- −3.7%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.